Evidence map›Paper›PMID 36582796›Full record

ArticleFrontiers in oncology2022

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma.

Juan Wang, Yixiao Yuan, Lin Tang, Haoqing Zhai, Dahang Zhang, Lincan Duan, Xiulin Jiang, Chen Li

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. In smokers, the axis NCAPG/hsa-let-7b-5p/TMPO-AS1 promotes lung adenocarcinoma.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Juan WangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Yixiao YuanDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Lin TangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Haoqing ZhaiLaboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, China.
Dahang ZhangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Lincan DuanDepartment of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiulin JiangLaboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, China.
Chen LiDepartment of Biology, Chemistry, Pharmacy, Free University of Berlin, Berlin, Germany.
Kunming Medical University · CNChinese Academy of Sciences · CNFreie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.921200.].

Indexed as

cell proliferationlung adenocarcinomaprognosis biomarkersstriatin-interacting protein 2tumor immune infiltration

Identifiers

PMID36582796
PMCPMC9793080
OpenAlexW4312138780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.